SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-19-015798
Filing Date
2019-05-06
Accepted
2019-05-06 06:46:30
Documents
69
Period of Report
2019-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q epzm-10q_20190331.htm 10-Q 1790650
2 EX-31.1 epzm-ex311_9.htm EX-31.1 8506
3 EX-31.2 epzm-ex312_8.htm EX-31.2 8469
4 EX-32.1 epzm-ex321_6.htm EX-32.1 6328
  Complete submission text file 0001564590-19-015798.txt   6284984

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT epzm-20190331.xml EX-101.INS 1211221
6 XBRL TAXONOMY EXTENSION SCHEMA epzm-20190331.xsd EX-101.SCH 55843
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE epzm-20190331_cal.xml EX-101.CAL 47368
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE epzm-20190331_def.xml EX-101.DEF 169148
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE epzm-20190331_lab.xml EX-101.LAB 424084
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE epzm-20190331_pre.xml EX-101.PRE 318429
Mailing Address 400 TECHNOLOGY SQUARE 4TH FLOOR CAMBRIDGE MA 02139
Business Address 400 TECHNOLOGY SQUARE 4TH FLOOR CAMBRIDGE MA 02139 617-229-5872
Epizyme, Inc. (Filer) CIK: 0001571498 (see all company filings)

IRS No.: 261349956 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35945 | Film No.: 19798032
SIC: 2834 Pharmaceutical Preparations